Hillsdale Investment Management’s inTEST INTT Stock Holding History

Hillsdale Investment Management’s Portfolio INTT Stock Details INTT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$770K	Buy	42,370 +20,700	+96%	+$350K	0.02%	417
2026 Q1	$296K	Buy	+21,670	New	+$238K	0.01%	518
2023 Q3	–	Sell	-4,200	Closed	-$110K	–	608
2023 Q2	$110K	Sell	4,200 -3,500	-45%	-$77.2K	0.01%	368
2023 Q1	$160K	Buy	7,700 +1,000	+15%	+$15K	0.01%	422
2022 Q4	$69K	Buy	+6,700	New	+$62.3K	0.01%	474
2019 Q3	–	Sell	-115,200	Closed	-$554K	–	647
2019 Q2	$554K	Sell	115,200 -6,000	-5%	-$34.6K	0.06%	307
2019 Q1	$814K	Buy	121,200 +700	+0.6%	+$5.04K	0.07%	164
2018 Q4	$739K	Buy	120,500 +20,000	+20%	+$137K	0.09%	167
2018 Q3	$779K	Hold	100,500	–	–	0.1%	151
2018 Q2	$734K	Buy	100,500 +2,300	+2%	+$16.3K	0.09%	174
2018 Q1	$653K	Hold	98,200	–	–	0.09%	157
2017 Q4	$849K	Hold	98,200	–	–	0.14%	168
2017 Q3	$815K	Buy	+98,200	New	+$745K	0.14%	155

Other funds holding INTT

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $551M AUM 49.99% 1-Year Est. Return

Hillsdale Investment Management's INTT Position: Q2 2026 in Review

Hillsdale Investment Management increased its inTEST (INTT) stake by 96% in Q2 2026, buying an estimated $350K and bringing the position to 42,370 shares worth $770K. The position accounts for 0.02% of the portfolio, ranked #417.

Hillsdale Investment Management first reported a position in INTT in Q3 2017 and has held it in 13 quarters since. The position peaked at $849K in Q4 2017. 90 funds tracked by Wall St. Rank hold INTT as of Q2 2026.

Hillsdale Investment Management held 42,370 shares of inTEST worth $770K as of Q2 2026.
Hillsdale Investment Management bought 20,700 inTEST shares in Q2 2026, an estimated $350K.
inTEST made up 0.02% of Hillsdale Investment Management's portfolio in Q2 2026, its #417 holding.
Hillsdale Investment Management first reported a position in inTEST in Q3 2017 and has held it in 13 quarters since.
Hillsdale Investment Management's inTEST position peaked at $849K in Q4 2017.
90 funds tracked by Wall St. Rank held inTEST as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.